Vivo Capital Fund VIII, L.P.

Insider profile

Vivo Capital Fund VIII, L.P.'s trades of Terns Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Proposed sale
Price
55.23
Quantity 33,647
Value US$1,432,766
Transaction date
Proposed sale
Price
74.44
Quantity 86,872
Value US$1,167,803
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-04-03 2024-04-03 PrS Proposed sale
33,647
55.23
US$1,432,766
33,647 55.23 US$1,432,766
2024-04-01 2024-04-01 PrS Proposed sale
86,872
74.44
US$1,167,803
86,872 74.44 US$1,167,803